Kane Biotech Inc V.KNE

Kane latest presentation (Dec.16th,2020) - Link

[francoisl13]

This biotech is very well managed (I said it many times over the last few years and it's true...).
Please find a link below to the latest presentation from Kane, you will find new information in regards to development and date target at which Kane wants to hit the market with their products (including DispersinB)....very interesting....especially when knowing that they rarely miss their targets. 
Kane Presentation (Dec. 16th 2020)
Love the potential. GLTA

[lscfa]

By Q2 2021 Kane will sign a partnership with US co. where US co. will pay $7 million Cdn to Kane for a 10% ownership in the partnership valuing this part of Kane business at $70 million.  Projecting $2M in revenues in 2022 and growing to $30M by 2025.

[MirrorWorldMan]

Its nice to be invested in a solid well resourced Canadian BioTech company with solid transparent partner deals in place and products that are commercialized, with rigid business plans and financing to make it work. A solid niche to make it work into the future and continual interest from identified sources that have committed stated dollar amounts in the years ahead...eh?

[StoneMan45]

actually states ..."DispersinB® Wound Care biofilm wash      PMA or BLA 1st Wound Care Bioburden claims        Launching in 2022 2024 Sales projections expected to top $25M USD.." that is 2024 (not 2025) and at current exchange rates that would be 32 million CND. The projected revenue is specific to the DispersinB Wound Care Biofilm Wash

[lscfa]

So slides 8 and 14 differ. Which is correct?    

[StoneMan45]

you are correct... either way it's a win but I'm hoping page 8